Global X Japan Co. Ltd. Decreases Position in Kenvue Inc. $KVUE

Key Points

• Global X Japan Co. Ltd. has reduced its stake in Kenvue Inc. by 50.1% during the second quarter, holding now 26,174 shares valued at approximately $548,000.
• Kenvue reported $0.29 earnings per share in its latest quarter, exceeding the consensus estimate of $0.28, although its revenue decreased by 4.0% year-over-year.
• The company recently declared a quarterly dividend increase to $0.2075 per share with a current annualized yield of 4.5%.

Global X Japan Co. Ltd. lowered its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 50.1% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,174 shares of the company's stock after selling 26,299 shares during the period. Global X Japan Co. Ltd.'s holdings in Kenvue were worth $548,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Evergreen Wealth Solutions LLC boosted its holdings in shares of Kenvue by 2.6% in the first quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock valued at $402,000 after purchasing an additional 432 shares during the period. Fulton Bank N.A. boosted its position in Kenvue by 0.6% during the first quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after acquiring an additional 465 shares during the last quarter. Scott & Selber Inc. increased its stake in Kenvue by 0.4% during the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock worth $2,557,000 after buying an additional 475 shares during the period. Wealth Alliance LLC grew its position in Kenvue by 1.6% in the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock worth $762,000 after purchasing an additional 486 shares during the last quarter. Finally, Everett Harris & Co. CA raised its holdings in shares of Kenvue by 1.4% during the first quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock valued at $887,000 after acquiring an additional 500 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

Analysts Set New Price Targets

KVUE has been the subject of several research reports. JPMorgan Chase & Co. lowered their price objective on shares of Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a research report on Friday, July 25th. Canaccord Genuity Group dropped their price objective on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a report on Friday, August 8th. Citigroup decreased their price target on Kenvue from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Tuesday, September 16th. Bank of America decreased their price target on Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, July 15th. Finally, UBS Group dropped their price objective on Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a research note on Thursday, July 17th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Kenvue currently has a consensus rating of "Hold" and a consensus target price of $24.04.

Kenvue Stock Up 1.3%

NYSE KVUE traded up $0.24 during trading hours on Friday, hitting $18.34. 49,471,497 shares of the company were exchanged, compared to its average volume of 27,946,758. The firm has a market cap of $35.20 billion, a price-to-earnings ratio of 17.14, a PEG ratio of 2.63 and a beta of 0.83. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52-week low of $17.15 and a 52-week high of $25.17. The company has a 50 day moving average of $20.87 and a two-hundred day moving average of $22.04.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue's revenue was down 4.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were issued a dividend of $0.2075 per share. This is a boost from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 annualized dividend and a yield of 4.5%. The ex-dividend date was Wednesday, August 13th. Kenvue's dividend payout ratio is presently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.